• Circle Pharma Raises $66 Million in Series C Financing PharmaSources
    June 17, 2021
    Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $66 million in an oversubscribed Series C financing.
PharmaSources Customer Service